BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
See today's BioWorld
Home
» Precithera eyes lucrative orphan bone market with C$36M series A
To read the full story,
subscribe
or
sign in
.
Precithera eyes lucrative orphan bone market with C$36M series A
July 28, 2017
By
Marie Powers
No Comments
Precithera Inc. completed a series A financing of C$36 million (US$29 million) from an investor syndicate that included Sanderling Ventures, Arix Bioscience Ltd., Fonds de solidarité FTQ, CTI Life Sciences and Emerillon Capital.
BioWorld